+1-617-945-9383
info@seluxdx.com
Selux Diagnostics Selux Diagnostics
Skip to content
  • Technology
  • Partners
  • Team
  • About
  • News
  • Contact
  • Careers
+1-617-945-9383
info@seluxdx.com

Category: Releases

 Category Releases

Selux Diagnostics Announces Additional $50 Million in Series C Funding

February 28, 2022
Read More
 Category Releases

Selux Diagnostics Announces Appointment of John Wilson as Chief Commercial Officer

November 16, 2021
Read More
 Category Releases

Selux Diagnostics Awarded $2.8 Million Grant from NIH for Commercialization of its NGP Platform

October 19, 2021
Read More
 Category Releases

Selux Diagnostics Earns FDA Breakthrough Device Designation for Next Generation ‘Phenotyping’ (NGP) Platform for Positive Blood Culture and Sterile Body Fluid Samples

September 28, 2021
Read More
 Category Releases

Selux Diagnostics Receives Additional $14.6 Million in BARDA Funding After Successfully Completing First Clinical Trial

June 9, 2021
Read More
 Category Releases

Selux Diagnostics Receives $9.6 Million in Additional Funding, Speeding Development of Breakthrough Rapid AST Platform

April 27, 2020
Read More
 Category Releases

ECCMID 2020 Alert: Selux Diagnostics Hosting Integrated Symposium at 30th European Congress of Clinical Microbiology & Infectious Diseases

February 18, 2020
Read More
 Category Releases

Selux Diagnostics Beats Key Contract Milestone, Receives $11.4M in Additional Funding

October 2, 2019
Read More
 Category Releases

Selux Diagnostics Selected to lead IDWeek 2019 Panel Presentation, Poster Session

September 10, 2019
Read More
 Category Releases

Selux Diagnostics Announces Selection of Three Abstracts for Poster Sessions at ASM Microbe Conference

June 10, 2019
Read More
Page 1 of 21 2 Next
Selux-Diagnostics-white-on-gray

We are a Boston-based company developing precision diagnostics for infectious diseases.

Contact

Technology

Partners

Team

About

News

Careers

Caution - The Selux platform is an Investigational Device, Limited by Federal Law to Investigational Use

Financial Conflict of Interest Policy

Copyright © 2021 Selux Diagnostics, Inc. All rights reserved.

